Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radioprotective effect of melatonin in patients with rectal cancer
IRCT2016021626586N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in rectal cancer and Acute Radiation Syndrome (ARS), sponsored by Babol University of Medical Sciences. Started Mar 2016; status: completed.
02
Drugs
melatonin
03
Conditions
rectal cancerAcute Radiation Syndrome (ARS)
Beyond the preview
Go deeper on IRCT2016021626586N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016021626586N1.